Shanghai Chicmax Cosmetic Co (2145) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of Shanghai Chicmax Cosmetic Co HK$52.67, price HK$20.78, upside +153.5%, quality 67 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.
How to read this chart
45‑month range HK$18.66 – HK$99.97 · fair‑value band HK$30.33 – HK$88.04 · the HK$20.78 price screens below the HK$52.67 fair value. Dashed = 300-day average. As of Oct 3, 2026.
Follow Shanghai Chicmax Cosmetic Co in your weekly email
Every Wednesday you see whether Shanghai Chicmax Cosmetic Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Shanghai Chicmax Cosmetic Co., Ltd., a multi-brand cosmetics company, engages in the research, development, manufacture, and sale of cosmetics in Mainland China and internationally.
Show more
Shanghai Chicmax Cosmetic Co., Ltd., a multi-brand cosmetics company, engages in the research, development, manufacture, and sale of cosmetics in Mainland China and internationally. The company offers mass and premium skincare; maternity, childcare, and teenage skin care; washing and personal care; makeup; dermocosmetics; face masks; and haircare and toiletry products under the KANS, One Leaf, Baby Elephant, asanami, KYOCA, newpage, ARMIYO, and ATISER brands. It also provides enterprise management, property leasing, and transportation services. The company sells its products through online and offline channels to retailers and distributors. The company was formerly known as Shanghai Kaka Cosmetic Co., Ltd. and changed its name to Shanghai Chicmax Cosmetic Co., Ltd. in 2020. Shanghai Chicmax Cosmetic Co., Ltd. was founded in 2002 and is headquartered in Shanghai, the People's Republic of China.
Stock analysis
Shanghai Chicmax Cosmetic Co (2145) currently trades at HK$20.78, while our model-based Fair Value estimate is HK$52.67, implying the stock looks roughly 60.5% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of HK$139.91 per share, and 25 of the 26 models we run sit above the HK$20.78 price.
Bear case: the Asset-Based group reads lowest at HK$5.45, and 1 of the 26 models stay below the price. Evidence for this calculation is high.
Scenario range: HK$30.33 (bear) to HK$88.04 (bull), the price of HK$20.78 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 67/100 (solid quality), in the Consumer Defensive sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Shanghai Chicmax Cosmetic Co reported revenue of 9.2B CNY in FY2025 versus 3.6B CNY in FY2021, a compound +26.2%/yr. Reported net income was 1.1B CNY in FY2025, compounding +34.3%/yr from FY2021.
Key figures
Market cap HK$8.3B (≈ $1.1B) · P/E ratio 10.3 · P/S ratio 1.24 · Dividend yield 3.6% · Net margin 12.0% · Return on equity 27.9% · Return on assets (EBIT) 14.4% · Operating margin 1.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 79% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at −29% fair-value upside, at 153%, 2145 screens cheaper than that median.
Fair Value models
Bear HK$30.33Fair Value HK$52.67Bull HK$88.04
Price HK$20.78 · Upside +153.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.90/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+35.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+50.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+22.1%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+21.3%
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
+41.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+37.4%
Dividend (yield on the price)3.6%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.8% → 12%
2025 sits 139% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−3.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+14.2%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in CNY, China: IMF forecast 1.7% a year to 2030, 1.4% from 2016 to 2025) that is about −4.8% a year for the price and +12.3% for the forecasts.
Compare Shanghai Chicmax Cosmetic Co with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 240 stocks
Beats the industry median on 10/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score67 · Top 25%
Fair Value upside+153.5% · Top 25%
Profitability
Return on equity (TTM)27.9% · Top 25%
Return on assets9.4% · Top 25%
Net margin (TTM)7.8% · Above median
Operating margin (TTM)1.6% · Below median
Growth and dividend
Revenue growth−8.6% · Bottom 25%
Dividend yield (TTM)3.6% · Above median
Valuation Multiplesvs Household & Personal Products median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Shanghai Chicmax Cosmetic Co Fair Value". https://www.fairvalue-calculator.com/stock/2145
Frequently asked questions
Is Shanghai Chicmax Cosmetic Co (2145) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of HK$52.67 versus a price of HK$20.78, about +153% upside (undervalued).
What is the fair value of 2145?
Our model-based fair value for Shanghai Chicmax Cosmetic Co is HK$52.67 (as of Oct 3, 2026), built from audited fundamentals. The current price: HK$20.78.
What is the quality score of 2145?
Shanghai Chicmax Cosmetic Co has a Quality Score of 67/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Shanghai Chicmax Cosmetic Co (2145)?
Our model-based price target is the fair value of HK$52.67 (as of Oct 3, 2026) from 26 valuation models. Cautious scenario HK$30.33, optimistic scenario HK$88.04. It is a calculation from audited fundamentals, not an analyst target.
What is the Shanghai Chicmax Cosmetic Co stock forecast for 2026?
Our models put fair value at HK$52.67, about +153% upside versus a price of HK$20.78 (undervalued). Cautious scenario HK$30.33, optimistic scenario HK$88.04. The calculation is refreshed regularly with new filings.
What is the revenue of Shanghai Chicmax Cosmetic Co (2145)?
Shanghai Chicmax Cosmetic Co reported trailing-twelve-month revenue of about 8.8B CNY (latest available figure, as of Oct 3, 2026).
Does Shanghai Chicmax Cosmetic Co pay a dividend?
Shanghai Chicmax Cosmetic Co currently shows a dividend yield of about 3.61% relative to its recent price (as of Oct 3, 2026).
What growth is priced into Shanghai Chicmax Cosmetic Co (2145)?
For today's price to be fair in a discounted-cash-flow model, Shanghai Chicmax Cosmetic Co would have to grow free cash flow by -3.2 % per year for five years (discount rate 10.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +22.1 % per year. As of Oct 3, 2026.
What discount rate (WACC) does the fair value of 2145 use?
Our models discount Shanghai Chicmax Cosmetic Co at 10.3 %: a base by market capitalisation (small), damped by beta 0.27, country premium for Hong Kong. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Shanghai Chicmax Cosmetic Co that is -3.2 % per year a year over ten years, using the same discount rate (10.3 %) and the same formula as our fair value.
How much growth has Shanghai Chicmax Cosmetic Co (2145) delivered so far?
Over the past 5 years revenue at Shanghai Chicmax Cosmetic Co grew +22.1 % a year. The price currently implies -3.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Shanghai Chicmax Cosmetic Co (2145) growing?
The median revenue growth in the sector is +3.3 % a year. That is the yardstick for the growth priced into Shanghai Chicmax Cosmetic Co (-3.2 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Shanghai Chicmax Cosmetic Co (2145)?
The free-cash-flow yield on the price is 9.78 %: that much free cash flow Shanghai Chicmax Cosmetic Co produces per unit of market value. When it exceeds the discount rate of our models (10.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Shanghai Chicmax Cosmetic Co (2145)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Shanghai Chicmax Cosmetic Co it is HK$52.67 per share (as of Oct 3, 2026), against a price of HK$20.78. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Shanghai Chicmax Cosmetic Co stock overvalued or undervalued in 2026?
As of Oct 3, 2026, 2145 trades below its calculated fair value: price HK$20.78, fair value HK$52.67, a gap of about +153% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 2145?
No. The price is what the market pays today (HK$20.78); the fair value is what the company's own numbers justify (HK$52.67). For Shanghai Chicmax Cosmetic Co the two are HK$31.89 per share apart. That gap is exactly why we show both numbers side by side.
How much is Shanghai Chicmax Cosmetic Co worth?
The market values Shanghai Chicmax Cosmetic Co at about HK$8.3B (market capitalisation, as of Oct 3, 2026). Per share that is HK$20.78; our models calculate a fair value of HK$52.67 per share.
What do the bullish and bearish scenarios say about 2145?
Our models span a range for Shanghai Chicmax Cosmetic Co: cautious scenario HK$30.33, base HK$52.67, optimistic HK$88.04 per share (as of Oct 3, 2026, price HK$20.78). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 2145?
Shanghai Chicmax Cosmetic Co trades at a price-to-earnings ratio of 10.3 (as of Oct 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of HK$52.67 is built from several models across several years. Other multiples: P/B 2.6, P/S 0.8, EV/EBITDA 7.5.
How solid is the balance sheet of Shanghai Chicmax Cosmetic Co (2145)?
Balance-sheet figures for Shanghai Chicmax Cosmetic Co (as of Oct 3, 2026): return on equity 27.9%. They feed the Quality Score of 67/100, which measures business quality independently of the share price.
How far is 2145 from its 52-week high?
Shanghai Chicmax Cosmetic Co trades at HK$20.78, about 79% below its 52-week high of HK$99.65 and 1% above the low of HK$20.50 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of HK$52.67 is for.
Which stocks are comparable to Shanghai Chicmax Cosmetic Co?
From the same area (Consumer Defensive) we also value Colgate-Palmolive Company, Hindustan Unilever Limited, Kenvue Inc, The Estée Lauder Companies Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Shanghai Chicmax Cosmetic Co stock attractive at the current price?
The data as of Oct 3, 2026: price HK$20.78, calculated fair value HK$52.67 (+153%), Quality Score 67/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 2145 calculated?
We run Shanghai Chicmax Cosmetic Co through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of HK$52.67, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.9 % above its aggregate fair value. Shanghai Chicmax Cosmetic Co currently trades 61 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Shanghai Chicmax Cosmetic Co (2145)?
The closing price on Oct 2, 2026 was HK$20.78. Our model-based fair value is HK$52.67, about +153% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Shanghai Chicmax Cosmetic Co right now?
The price is below even our cautious bear case (HK$30.33). The market is more pessimistic than our downside scenario. The model range is unusually wide (HK$30.33 to HK$88.04). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid quality (67/100) at a price below fair value, the discount is the argument here, not the business quality.
Key figures of Shanghai Chicmax Cosmetic Co
How large is the market capitalisation of Shanghai Chicmax Cosmetic Co (2145)?
The market capitalisation of Shanghai Chicmax Cosmetic Co is HK$8.3B (≈ $1.1B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Shanghai Chicmax Cosmetic Co (2145)?
The price-to-sales ratio of Shanghai Chicmax Cosmetic Co is 1.24 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Shanghai Chicmax Cosmetic Co (2145)?
The dividend yield of Shanghai Chicmax Cosmetic Co is 3.6%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Shanghai Chicmax Cosmetic Co (2145)?
The net margin of Shanghai Chicmax Cosmetic Co is 12.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Shanghai Chicmax Cosmetic Co (2145)?
The return on equity (ROE) of Shanghai Chicmax Cosmetic Co is 27.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Shanghai Chicmax Cosmetic Co (2145)?
On an EBIT basis the return on assets of Shanghai Chicmax Cosmetic Co is 14.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Shanghai Chicmax Cosmetic Co (2145)?
The operating margin of Shanghai Chicmax Cosmetic Co is 1.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Shanghai Chicmax Cosmetic Co (2145)?
Revenue at Shanghai Chicmax Cosmetic Co is growing −8.6% versus a year earlier (3y avg +50.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Shanghai Chicmax Cosmetic Co (2145)?
Earnings per share at Shanghai Chicmax Cosmetic Co are growing −79.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Shanghai Chicmax Cosmetic Co (2145) hold?
Shanghai Chicmax Cosmetic Co holds more cash than debt, 177M CNY net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Shanghai Chicmax Cosmetic Co in the live analysis
One click puts Shanghai Chicmax Cosmetic Co on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
